WebDec 15, 2011 · Inhibiting GCH1 as the rate limiting and obligate first step of this pathway produces analgesia in animals, but the therapeutic index for GCH1 inhibitors might be relatively limited if basal BH4 levels are reduced at doses required to decrease pathologically elevated levels. Colorectal cancer (CRC) is the second deadliest cancer worldwide (Bray et al., 2024). The global burden of CRC is expected to rise by 60% to more than 2.2 million new cases and 1.1 million deaths by 2030 (Arnold et al., 2024). Although immunotherapy and molecular-targeted therapy are developing, chemotherapy is … See more The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be … See more Induction of ferroptosis is a potential therapeutic strategy for tumor eradication (Hassannia et al., 2024; Chen et al., 2024). However, the underlying mechanisms of … See more
GCH1 variants, tetrahydrobiopterin and their effects on
WebJun 17, 2012 · The observed effects of GCH1 inhibition in the tumor model and its enhancement of morphine-evoked antinociception without increase of morphine toxicity suggest that GCH1 inhibitors might be useful ... WebNov 29, 2024 · The FSP1 inhibitor iFSP1, which induced ferroptosis in GPX4-knockdown cells and FSP1-overexpressing cells, ... Therefore, the implication of GCH1–BH 4 /BH 2 axis in inhibiting ferroptosis can be either by directly playing the intracellular antioxidant role in protecting cell membrane phospholipids, ... apurba chatterjee omaha
GPX4-independent ferroptosis—a new strategy in …
WebAug 27, 2024 · GCH1 activity and BH4 level are decreased in irradiated mesenteric artery and endothelial cells. Administration of a GCH1 inhibitor DAHP significantly aggravates vascular injury and intestinal damage, while BH4 treatment can improve intestinal vascular injury and ischemia induced by ionizing radiation, and restore vascular function ( 53 ). WebAug 31, 2024 · Increased tetrahydrobiopterin (BH4) generated in injured sensory neurons contributes to increased pain sensitivity and its persistence. GTP cyclohydrolase 1 (GCH1) is the rate-limiting enzyme in the de novo BH4 synthetic pathway, and human single-nucleotide polymorphism studies, together with mouse genetic modeling, have … WebNov 28, 2024 · GCH1 is a rate-limiting enzyme for the synthesis of BH4 which was significantly elevated by overexpression of SPY1 as well and turned decreased after the … apurba gohain